Product Program year 2019 Source: CMS Open Payments

Non-Covered

Drug

Open in the dashboard

General payments

$1,036,880

1,216 payments

Research payments

$0

0 payments

Through program year 2019, $1,036,880 in general payments and $0 in research payments were reported against Non-Covered.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $1,036,880 1,216

Breakdown

Who paid General payments · program year 2019
  1. Bayer HealthCare Pharmaceuticals Inc. $1,036,880 1,216 payments
Top recipients General payments · program year 2019
  1. Murray Epstein Hospitalist · Miami, FL $73,113 7% · 33 payments
  2. Darius Moshfeghi Retina Specialist · Palo Alto, CA $48,959 5% · 5 payments
  3. Bertram Pitt Cardiovascular Disease · Ann Arbor, MI $40,547 4% · 25 payments
  4. Ravi Thadhani Nephrology · Boston, MA $40,130 4% · 22 payments
  5. Jeffery Testani Cardiovascular Disease · New Haven, CT $39,855 4% · 11 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Urology $163,562 16% · 36 practitioners
  2. Cardiovascular Disease Internal Medicine $158,361 16% · 16 practitioners
  3. Medical Oncology Internal Medicine $128,184 13% · 22 practitioners
  4. Nephrology Internal Medicine $125,872 12% · 27 practitioners
  5. Endocrinology, Diabetes & Metabolism Internal Medicine $73,777 7% · 15 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $157,330 15% · 28 recipients
  2. Florida $102,322 10% · 8 recipients
  3. Massachusetts $69,336 7% · 10 recipients
  4. Texas $62,987 6% · 11 recipients
  5. New York $56,147 5% · 15 recipients

The top 5 of 33 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

1,216 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record